KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 122 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $48,095 | -40.5% | 53,091 | -0.9% | 0.00% | – |
| Q1 2024 | $80,880 | +107.7% | 53,563 | +18.3% | 0.00% | – |
| Q4 2023 | $38,949 | -35.5% | 45,290 | +0.8% | 0.00% | – |
| Q3 2023 | $60,428 | +170.4% | 44,928 | +265.9% | 0.00% | – |
| Q2 2023 | $22,348 | -52.3% | 12,279 | 0.0% | 0.00% | – |
| Q1 2023 | $46,844 | -68.6% | 12,279 | -13.8% | 0.00% | – |
| Q1 2021 | $149,000 | -54.8% | 14,239 | -33.8% | 0.00% | – |
| Q4 2020 | $330,000 | +16.6% | 21,525 | +12.1% | 0.00% | – |
| Q3 2020 | $283,000 | -20.1% | 19,198 | +2.7% | 0.00% | -100.0% |
| Q2 2020 | $354,000 | +40.5% | 18,688 | +39.5% | 0.00% | 0.0% |
| Q1 2020 | $252,000 | – | 13,397 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,827,078 | $82,205,000 | 4.43% |
| Palo Alto Investors LP | 4,663,324 | $79,416,000 | 3.21% |
| Private Capital Advisors, Inc. | 473,901 | $8,071,000 | 2.23% |
| DOHENY ASSET MANAGEMENT /CA | 215,445 | $3,669,000 | 1.92% |
| Sandia Holdings, LLC | 119,739 | $2,039,000 | 0.96% |
| Capital Impact Advisors, LLC | 102,006 | $1,744,000 | 0.60% |
| Birchview Capital, LP | 50,000 | $852,000 | 0.55% |
| EMERALD ADVISERS, LLC | 694,068 | $11,820,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 647,307 | $11,024,000 | 0.37% |
| Schonfeld Strategic Advisors LLC | 418,100 | $7,121,000 | 0.32% |